Our paper on Golcadomide is published in Blood Cancer Discovery

Excited to share that our work on Golcadomide, an oral CELMoD agent targeting IKZF1/3 for Diffuse Large B-Cell Lymphoma, has been published in Blood Cancer Discovery!

This study demonstrates how molecular glue degraders can selectively eliminate cancer cells by hijacking the ubiquitin-proteasome system.